PharmaShots Weekly Snapshot (October 28 - November 01, 2019)
Published: Oct 31, 2019 | Tags: Medtronic, Reports, MHLW, Shonin Approval, Launches, Valiant Navion Thoracic Stent Graft System, Japan ?
?2. Beam Therapeutics Signs Exclusive License Agreement with Prime Medicine for Prime Editing Technology
Published: Oct 31, 2019 | Tags: Beam Therapeutics, Signs, Exclusive, License Agreement, Prime Medicine, Prime Editing Technology
Published: Oct 31, 2019 | Tags: Vertex, Reports, Results, Trikafta, elexacaftor, tezacaftor, ivacaftor, P-III Studies, Cystic Fibrosis ?
4. AbbVie Reports Results of Rinvoq (upadacitinib) in P-III SELECT-PsA 2 Study for Psoriatic Arthritis
Published: Oct 30, 2019 | Tags: AbbVie, Reports, Results, Rinvoq, upadacitinib, P-III, SELECT-PsA 2, Study, Psoriatic Arthritis
Published: Nov 01, 2019 | Tags: Novartis, Reports, Results, Cosentyx, secukinumab, Head to Head, P-III, EXCEED Study, Psoriatic Arthritis
7. ?? Amgen Acquires Stake in BeiGene to Expand its Oncology Portfolio in China
Published: Oct 31, 2019 | Tags: Amgen, Signs, Strategic, Collaboration, BeiGene, Expand, Oncology Portfolio, China
Published: Oct 30, 2019 | Tags: Janssen, Darzalex, daratumumab, Combination, Regimen, Receives, Health Canada, Approval, Transplant Ineligible Patients, Multiple Myeloma??
Published: Oct 31, 2019 | Tags: Roche, Signs, Development, Commercialization, Agreement, Dicerna, DCR-HBVS, Chronic Hepatitis B Virus Infection
10. ? AliveCor and Huami Collaborate to Bring the Next Generation ECG Wearables Devices
Published: Oct 30, 2019 | Tags: AliveCor, Huami, Collaborate, Bring, Next Generation, Medical Wearables Devices
Published: Oct 31, 2019 | Tags: Johnson & Johnson Vision, Launches, TECNIS Eyhance, Monofocal Intraocular Lens, Post Cataract Surgery Patients, India
Published: Oct 30, 2019 | Tags: Astellas, Signs, Exclusive, License Agreement, Pandion, Deliver, Immunomodulators, Autoimmune Diseases, Pancreas
Published: Oct 30, 2019 | Tags: Pear Therapeutics, Signs, Agreement, Ironwood, Assess, Prescription Digital Therapeutics, GI Indications
14. ?? Biogen and Alkermes Vumerity (diroximel fumarate) Receive FDAs Approval for Multiple Sclerosis
Published: Oct 30, 2019 | Tags: Biogen, Alkermes, Vumerity, diroximel fumarate, Receive, FDA, Approval, Multiple Sclerosis
15. ? LEO Pharma Signs an Option Agreement with Ubiquigent to Access its Two Novel Therapies
Published: Oct 30, 2019 | Tags: LEO Pharma, Signs, Option Agreement, Ubiquigent, Access, Two, Novel Therapies
Published: Oct 30, 2019 | Tags: Novartis, Reports, FDA, Hold, P-I/II, Intrathecal, Zolgensma/AVXS-101, onasemnogene abeparvovec-xioi, Spinal Muscular Atrophy Type 2
Published: Oct 30, 2019 | Tags: Roche, Reports, EMA, FDA, Acceptance, Marketing Application, Satralizumab, Treat, Neuromyelitis Optica Spectrum Disorder
18. ? AstraZeneca Divests Rights of Seroquel and Seroquel XR to Cheplapharm in Europe and Russia
Published: Oct 30, 2019 | Tags: AstraZeneca, Divests, Rights, Seroquel, Seroquel XR, Cheplapharm, Europe, Russia
Published: Oct 30, 2019 | Tags: GSK, Intravenous, Benlysta, belimumab, Receives, EC, Approvals, First Biologic, Treat, Lupus, Children
Published: Oct 21, 2019 | Tags: Boehringer Ingelheim, Collaborates, The Defeat-NCD Partnership, Tackle, Impacts, Non-Communicable Diseases
Published: Oct 22, 2019 | Tags: Astellas, ASP1128, Receives, US, FDA, Fast Track Designation, Patients, High Risk, Acute Kidney Injury
Published: Oct 21, 2019 | Tags: MorphoSys, Galapagos, Collaboration, Novartis, Terminate, Clinical Development, MOR106, Atopic Dermatitis
Published: Oct 21, 2019 | Tags: GSK, Reports, Results, M72/AS01E, P-IIb, Prevention, Pulmonary Tuberculosis Disease
Published: Oct 21, 2019 | Tags: Pfizer, Bavencio, Avelumab, Axitinib, Dual Regimen, Receives, EC, Approval,1L treatment, Advanced Renal Cell Carcinoma
Published: Oct 21, 2019 | Tags: AstraZeneca, Reports, Results, Imfinzi, durvalumab, Tremelimumab, P-III, POSEIDON, Study, 1L, Treatment, Stage IV, Non-Small Cell Lung Cancer
?26. Gilead Collaborates with Glympse Bio to Utilize Biomarker Technology in NASH Clinical Program
Published: Oct 21, 2019 | Tags: Gilead, Collaborates, Glympse Bio, Utilize, Biomarker Technology, NASH Clinical Program?
Tags
This content piece was prepared by our former Senior Editor. She had expertise in life science research and was an avid reader. For any query reach out to us at connect@pharmashots.com